赫斯佩里丁,甲基赫斯佩里丁和赫斯佩里丁甲基 chalcone 与卵胺的相互作用机制和结构-活性关系:一项比较研究
Xuefei Wen1, Xinpeng Li1, Siming Zhu2
1School of Food Science and Engineering, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, Engineering Research Center of Starch and Vegetable Protein Processing Ministry of Education, South China University of Technology, Guangzhou 510640, China.
素衍生物与卵素 (OVA) 相互作用,改变其结构并增强抗氧化和乳化特性. 黄酸的结构差异显著影响这些功能变化.
科学领域:
- 生物化学 生物化学
- 食品科学 食品科学 食品科学
- 分子生物物理学 分子生物物理学
背景情况:
- 卵蛋白 (OVA) 是卵白中的主要蛋白质,具有各种功能性质.
- 黄酸是具有已知的生物活性的植物化合物.
- 了解蛋白质 - 黄类相互作用对于食品和制药应用至关重要.
研究的目的:
- 为了研究卵素 (OVA) 和三种基于hesperidin的黄类衍生物之间的相互作用机制.
- 阐明管理这些相互作用的结构-活动关系.
- 评估这些相互作用对OVA功能和抗氧化特性的影响.
主要方法:
- 多光谱分析 (光光谱学)
- 计算机模拟 (分子对接,分子动力学)
- 热力学参数分析的方法
主要成果:
- 黑素 (HSD),甲基黑素 (MH) 和黑素甲基 (HMC) 诱导了OVA光的静态火,HMC > MH > HSD.
- 确定了结合作为一个关键的相互作用力.
- 黄化合物结合改变了OVA的形状,二次结构,并降低了疏水性.
- 黄-OVA复合物显示出增强的抗氧化特性.
- 黄类结构影响了结合亲和力和OVA的乳化能力.
结论:
- 赫斯佩里丁衍生物的轻微结构变异显著影响它们与OVA的相互作用.
- 这些相互作用调节OVA的功能性质,包括乳化和抗氧化能力.
- 这项研究提供了有关黄类蛋白相互作用的见解,用于食品科学和营养方面的潜在应用.
相关概念视频
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics


